Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

A Retrospective Cohort Study of Urgent Care Visits and Revisits for Headache and Migraine in New York City
Headache
P15 - Poster Session 15 (12:00 PM-1:00 PM)
7-011
We sought to examine the frequency of headache visits and revisits among patients who present to an urgent care for management of headache, in particular migraine.
There has been a rapid increase in the number of urgent care centers in the US. Little is known about the healthcare utilization of those who visit urgent care centers for headache.
We conducted a retrospective cohort study of visits from 67 NYC urgent care centers with chief complaints and discharge diagnoses of headache and/or migraine in the first eight months of 2018. Descriptive analyses were used to determine the frequency of headache revisit within six months of an index urgent care visit and the elapsed time to revisit. Using multivariable logistic regression, we assessed associations between age, sex, and revisit.
There were 10,240 patients with an index visit to a NYC urgent care location. Of this sample, 5.5% (N=564) patients had at least one revisit to urgent care. The majority of patients, 6994 (68.3%) were female, and the mean age was 35.1 (SD: 15.0 years). The vast majority, 93.9% (N=9613) lived within 60 miles of NYC, and 90.6% of all patients were NYC residents. Among re-visitors, the mean frequency visit to urgent care was 2.2 (SD: 0.7 times). Patients waited on average 61.3 days (SD: 55.2 days) to revisit.  The majority of revisits (64.3%) happened within 90 days. There were no differences between age and sex and revisits.

In just eight months, there were over 10,000 headache urgent care visits in NYC. More than half of headache/migraine urgent care revisits happened within 90 days of the index visit. Future work should look at the types of treatment administered at urgent care centers for headache or migraine in order to provide a better understanding of how to optimize acute headache management in these centers.
Authors/Disclosures
Kina Zhou
PRESENTER 		No disclosure on file
Benjamin W. Friedman, MD, MS Benjamin W. Friedman, MD, MS has nothing to disclose.
No disclosure on file
Mia T. Minen, MD, FÂ鶹´«Ã½Ó³»­ (NYULMC Neurology) The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .